312 related articles for article (PubMed ID: 15936755)
1. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
Asally M; Yoneda Y
Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
[TBL] [Abstract][Full Text] [Related]
3. New evidence that nuclear import of endogenous beta-catenin is LEF-1 dependent, while LEF-1 independent import of exogenous beta-catenin leads to nuclear abnormalities.
Kim K; Hay ED
Cell Biol Int; 2001; 25(11):1149-61. PubMed ID: 11913959
[TBL] [Abstract][Full Text] [Related]
4. A novel isoform of human lymphoid enhancer-binding factor-1 (LEF-1) gene transcript encodes a protein devoid of HMG domain and nuclear localization signal.
Kobielak A; Kobielak K; Trzeciak WH
Acta Biochim Pol; 2001; 48(1):221-6. PubMed ID: 11440173
[TBL] [Abstract][Full Text] [Related]
5. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
[TBL] [Abstract][Full Text] [Related]
6. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.
Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042
[TBL] [Abstract][Full Text] [Related]
7. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
Tutter AV; Fryer CJ; Jones KA
Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
[TBL] [Abstract][Full Text] [Related]
8. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.
von Kries JP; Winbeck G; Asbrand C; Schwarz-Romond T; Sochnikova N; Dell'Oro A; Behrens J; Birchmeier W
Nat Struct Biol; 2000 Sep; 7(9):800-7. PubMed ID: 10966653
[TBL] [Abstract][Full Text] [Related]
9. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
Schmidt M; Patterson M; Farrell E; Münsterberg A
Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.
Kim K; Lee KY
Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329
[TBL] [Abstract][Full Text] [Related]
11. A comparative evaluation of beta-catenin and plakoglobin signaling activity.
Williams BO; Barish GD; Klymkowsky MW; Varmus HE
Oncogene; 2000 Nov; 19(50):5720-8. PubMed ID: 11126358
[TBL] [Abstract][Full Text] [Related]
12. Wnt signalling: a theme with nuclear variations.
Sharpe C; Lawrence N; Martinez Arias A
Bioessays; 2001 Apr; 23(4):311-8. PubMed ID: 11268036
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
de la Taille A; Rubin MA; Chen MW; Vacherot F; de Medina SG; Burchardt M; Buttyan R; Chopin D
Clin Cancer Res; 2003 May; 9(5):1801-7. PubMed ID: 12738737
[TBL] [Abstract][Full Text] [Related]
14. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
[TBL] [Abstract][Full Text] [Related]
16. Analysis of beta-catenin aggregation and localization using GFP fusion proteins: nuclear import of alpha-catenin by the beta-catenin/Tcf complex.
Giannini AL; Vivanco MM; Kypta RM
Exp Cell Res; 2000 Mar; 255(2):207-20. PubMed ID: 10694436
[TBL] [Abstract][Full Text] [Related]
17. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
[TBL] [Abstract][Full Text] [Related]
18. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM
Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259
[TBL] [Abstract][Full Text] [Related]
19. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin.
Fagotto F; Glück U; Gumbiner BM
Curr Biol; 1998 Feb; 8(4):181-90. PubMed ID: 9501980
[TBL] [Abstract][Full Text] [Related]
20. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
